Our Philosophy: At Novo Nordisk, with each new treatment we develop, and every new patient we meet, we are expanding our commitment to helping people live better lives. Together with patients and the people who care for them, we are working toward bigger goals and visions for our world, and with any new advancement comes the question, What’s next?  For more than three decades, one of our main focuses has been Changing Hemophilia®. We are changing how people with hemophilia A and B, acquired hemophilia, factor FXIII deficiency, Factor VII deficiency, Glanzmann thrombasthenia, and congenital hemophilia with inhibitors, live and how health care providers understand these conditions.